查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1449396

痔瘡治療市場、佔有率、市場規模、趨勢、行業分析報告：按藥物類型、按治療類型、按應用、按最終用途、按地區、按細分市場、預測，2024-2032 年

Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, & Segment Forecasts, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球肛門瘺治療市場規模將達到413.4億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於全球肛瘺盛行率上升，肛瘺治療市場正在經歷成長。 發炎性腸道疾病是導致胃腸道（GI）持續慢性發炎且沒有可識別觸發因素的主要原因。 腸造口治療領域的收入成長取決於預測期內產品開發的進步、藥物批准以及對生物製劑和生物相似藥的日益偏好等因素。

單細胞 RNA 定序等技術進步正在幫助醫療保健專業人員管理肛瘺治療。 單細胞RNA定序和質譜流式細胞儀等高維度技術已應用於從診斷為克隆氏症和潰瘍性結腸炎的患者身上取得的腸道標本。 單細胞 RNA 定序分析的使用為瞭解疾病的分子基礎提供了多種好處，包括探索創新的治療策略、客製化個別藥物和預防疾病。

多種因素導致肛瘺治療市場的盛行率不斷上升，包括遺傳傾向、環境觸發因素以及通常與克隆氏症相關的免疫系統失調。 被診斷患有潰瘍性結腸炎或克隆氏症的患者中有很大一部分有家族史。 例如，霍普金斯醫學院的一項研究發現，大約 10% 至 15% 的克羅恩病患者的親屬患有克羅恩病。 同樣，大約 5% 至 7% 被診斷出患有潰瘍性結腸炎的患者有家族史。

業界領導者為降低醫療成本而實施的報銷策略預計將推動患者對有效治療方案的良好認知。 增加對腸造口治療的投資也能帶來顯著的投資回報 (ROI)，特別是當醫生通常開立這些藥物來治療中度至重度腸造口疾病時。據預測， 此外，抗黏連分子，特別是整合素拮抗劑的開發，代表了解決肛門瘺的一個有前途的途徑。 這些分子標靶參與沾黏形成的分子機制，有可能減少瘺管復發並改善患者預後。

肛瘺治療市場報告亮點

2023 年，在幹預措施的推動下，外科手術佔了最大的市場佔有率，尤其是瘺管手術，它成為治療肛門瘺的患者的推薦和首選方法。

由於醫院部門擁有先進的醫療基礎設施（包括手術室和診斷能力），因此醫院部門預計在預測期內的複合年增長率將是最快的。

北美由於其先進的醫療基礎設施、設備齊全的醫院、診所和專業醫療設施，在 2023 年佔最大的市場佔有率。 獲得最先進的診斷和治療資源有助於有效和全面的肛瘺管理。

由於存在大量患有腸道疾病的人口，預計亞太地區在預測期內複合年增長率最快。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球肛瘺治療市場洞察

  • 肛門瘺治療 - 產業快照
  • 肛瘺治療市場動態
    • 推動者和機會
      • 腸道疾病的發生率增加
      • 處理技術的進步
    • 抑制因素和挑戰
      • 治療費用高
  • 杵分析
  • 肛瘺治療產業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球肛門瘺治療市場（依藥物類型）

  • 主要發現
  • 簡介
  • 抗膽鹼能作用
  • 質子幫浦抑制劑
  • H2 阻斷劑
  • 止瀉

第6章全球肛門瘺治療市場，依應用劃分

  • 主要發現
  • 簡介
  • 括約肌間瘺管
  • 經括約肌瘺
  • 括約肌上瘺管
  • 其他

第7章全球肛門瘺治療市場，依最終用途劃分

  • 主要發現
  • 簡介
  • 醫院
  • 門診手術中心
  • 其他

第 8 章全球肛瘺治療市場（依治療類型）

  • 主要發現
  • 簡介
  • 手術
  • 非手術

第 9 章全球肛門瘺治療市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年肛門瘺治療市場評估（按地區）
  • 肛門瘺治療市場 - 北美
    • 北美：肛瘺治療市場，依藥物類型，2019-2032 年
    • 北美：2019-2032 年肛瘺治療市場（依治療類型）
    • 北美：2019-2032 年肛門瘺治療市場（依應用）
    • 北美：肛瘺治療市場，依最終用途，2019-2032 年
    • 肛門瘺治療市場—美國
    • 肛瘺治療市場 - 加拿大
  • 肛門瘺治療市場 - 歐洲
    • 歐洲：2019-2032 年肛門瘺治療市場（依藥物類型）
    • 歐洲：2019-2032 年肛瘺治療市場（依治療類型）
    • 歐洲：肛瘺治療市場，依應用劃分，2019-2032 年
    • 歐洲：肛瘺治療市場（依最終用途），2019-2032 年
    • 肛門瘺治療市場 - 英國
    • 肛門瘺治療市場 - 法國
    • 肛門瘺治療市場 - 德國
    • 肛門瘺治療市場 - 義大利
    • 肛瘺治療市場 - 西班牙
    • 肛門瘺治療市場 - 荷蘭
    • 肛門瘺治療市場 - 俄羅斯
  • 肛瘺治療市場 - 亞太地區
    • 亞太地區：肛門瘺治療市場（依藥物類型），2019-2032 年
    • 亞太地區：肛門瘺治療市場（依治療類型），2019-2032 年
    • 亞太地區：肛門瘺治療市場，依應用劃分，2019-2032 年
    • 亞太地區：肛門瘺治療市場（依最終用途），2019-2032 年
    • 肛門瘺治療市場 - 中國
    • 肛瘺治療市場 - 印度
    • 肛瘺治療市場—日本
    • 肛門瘺治療市場 - 馬來西亞
    • 肛門瘺治療市場—印度尼西亞
    • 肛瘺治療市場－韓國
  • 痔瘡治療市場 - 中東和非洲
    • 中東與非洲：肛門瘺治療市場（依藥物類型），2019-2032 年
    • 中東與非洲：2019-2032 年肛瘺治療市場（依治療類型）
    • 中東與非洲：肛門瘺治療市場，依應用劃分，2019-2032 年
    • 中東和非洲：肛門瘺治療市場（以最終用途），2019-2032 年
    • 肛瘺治療市場－沙烏地阿拉伯
    • 肛門瘺治療市場 - 南非
    • 肛門瘺治療市場 - 以色列
    • 肛門瘺治療市場 - 阿拉伯聯合大公國
  • 肛門瘺治療市場 - 拉丁美洲
    • 拉丁美洲：肛瘺治療市場，依藥物類型，2019-2032 年
    • 拉丁美洲：2019-2032 年肛瘺治療市場（依治療類型）
    • 拉丁美洲：肛瘺治療市場，按應用劃分，2019-2032 年
    • 拉丁美洲：肛瘺治療市場，依最終用途，2019-2032 年
    • 肛門瘺治療市場 - 墨西哥
    • 肛門瘺治療市場 - 巴西
    • 肛瘺治療市場—阿根廷

第10章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第11章公司簡介

  • Angiplast Pvt. Ltd.
  • Avante Health Solutions
  • Biolitec AG
  • Cliniva Healthcare
  • Cook Medical
  • Gulmaher Surgico
  • Integra LifeSciences
  • KARL STORZ
  • Medtronic plc
  • Novo Surgical Inc.
  • Signum Surgical
  • Sklar Surgical Instruments
Product Code: PM4582

The global anal fistula treatment market size is expected to reach USD 41.34 billion by 2032, according to a new study by Polaris Market Research. The report "Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The anal fistula treatment market is experiencing growth propelled by the global increase in the prevalence of this condition. Inflammatory bowel diseases are a primary cause, leading to persistent chronic inflammation of the gastrointestinal (GI) tract without identifiable triggers. Revenue expansion in the intestinal fistula treatment sector is anticipated due to factors like advancements in product development, drug approvals, and a growing preference for biologic and biosimilar medications throughout the forecast period.

Advancements in technology, exemplified by single-cell RNA sequencing, are aiding healthcare practitioners in managing anal fistula treatment. High-dimensional techniques like single-cell RNA sequencing and mass cytometry have been applied to intestinal specimens obtained from individuals diagnosed with Crohn's disease or ulcerative colitis. The utilization of single-cell RNA sequencing analysis offers various advantages in comprehending the molecular underpinnings of the disease, including the exploration of innovative therapeutic strategies, customization of individual medications, and disease prevention.

Multiple factors contribute to the escalating prevalence of the anal fistula treatment market, including genetic predisposition, environmental triggers, and immune system dysregulation, often associated with the Crohn's Disease. A significant proportion of patients diagnosed with ulcerative colitis or Crohn's disease exhibit a familial history of the condition. For instance, research conducted by Hopkins Medicine indicates that approximately 10 to 15% of individuals with Crohn's disease have relatives affected by the disorder. Similarly, around 5 to 7% of patients diagnosed with ulcerative colitis have a familial history of the condition.

Reimbursement strategies implemented by key industry players to mitigate healthcare costs are expected to foster favorable patient perceptions regarding effective treatment options. Increased investments in intestinal fistula treatment are also projected to yield significant returns on investment (ROI), particularly as physicians commonly prescribe these medications for managing moderate to severe intestinal fistula cases. Furthermore, the development of anti-adhesion molecules, particularly integrin antagonists, presents a promising avenue for addressing anal fistula. These molecules target the molecular mechanisms involved in adhesion formation, potentially reducing the recurrence of fistulas and improving patient outcomes.

Anal Fistula Treatment Market Report Highlights

In 2023, the surgical segment accounted for the largest market share due to interventions, particularly fistula surgery, that emerged as the recommended and preferred approach for addressing anal fistulas among patients.

The hospital segment is expected to witness the fastest CAGR during the forecast period due to specialized departments and facilities equipped with advanced medical infrastructure, including surgical units and diagnostic capabilities.

North America dominated the largest market share in 2023, due to advanced healthcare infrastructure with well-equipped hospitals, clinics, and specialized healthcare facilities. The availability of state-of-the-art diagnostic and treatment resources contributes to effective and comprehensive anal fistula management.

Asia Pacific region is expected to witness the fastest CAGR during the forecast period on account of the presence of a huge population suffering from intestinal disorders.

The global players include Avante Health, Biolitec, Cliniva Healthcare, Cook Medical, Gulmaher Surgico, KARL STORZ, Novo Surgical, and more.

Polaris Market Research has segmented the anal fistula treatment market report based on drug type, treatment type, application, end use, and region:

Anal Fistula Treatment, Durg Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Anticholinergic
  • Proton-Pump Inhibitors
  • H2 Blockers
  • Antidiarrheals

Anal Fistula Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Surgical
  • Non-Surgical

Anal Fistula Treatment, Application Outlook (Revenue - USD Billion, 2019- 2032)

  • Intersphincteric Fistula
  • Transsphincteric Fistula
  • Suprasphincteric Fistula
  • Others

Anal Fistula Treatment, End Use Outlook (Revenue - USD Billion, 2019- 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Anal Fistula Treatment, Regional Outlook (Revenue - USD Billion, 2019- 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Anal Fistula Treatment Market Insights

  • 4.1.Anal Fistula Treatment - Industry Snapshot
  • 4.2.Anal Fistula Treatment Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Rising incidence of bowel diseases
      • 4.2.1.2.Advancements in Treatment Technologies
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.High cost of treatment
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Anal Fistula Treatment Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Anal Fistula Treatment Market, by Drug Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3.Anticholinergic
    • 5.3.1.Global Anal Fistula Treatment Market, by Anticholinergic, by Region, 2019-2032 (USD Billion)
  • 5.4.Proton-Pump Inhibitors
    • 5.4.1.Global Anal Fistula Treatment Market, by Proton-Pump Inhibitors, by Region, 2019-2032 (USD Billion)
  • 5.5.H2 Blockers
    • 5.5.1.Global Anal Fistula Treatment Market, by H2 Blockers, by Region, 2019-2032 (USD Billion)
  • 5.6.Antidiarrheals
    • 5.6.1.Global Anal Fistula Treatment Market, by Antidiarrheals, by Region, 2019-2032 (USD Billion)

6.Global Anal Fistula Treatment Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Intersphincteric Fistula
    • 6.3.1.Global Anal Fistula Treatment Market, by Intersphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.4.Transsphincteric Fistula
    • 6.4.1.Global Anal Fistula Treatment Market, by Transsphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.5.Suprasphincteric Fistula
    • 6.5.1.Global Anal Fistula Treatment Market, by Suprasphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.6.Others
    • 6.6.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Anal Fistula Treatment Market, by End-use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 7.3.Hospitals
    • 7.3.1.Global Anal Fistula Treatment Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 7.4.Ambulatory Surgical Centers
    • 7.4.1.Global Anal Fistula Treatment Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Anal Fistula Treatment Market, by Treatment Type

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 8.3.Surgical
    • 8.3.1.Global Anal Fistula Treatment Market, by Surgical, by Region, 2019-2032 (USD Billion)
  • 8.4.Non-Surgical
    • 8.4.1.Global Anal Fistula Treatment Market, by Non-Surgical, by Region, 2019-2032 (USD Billion)

9.Global Anal Fistula Treatment Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Anal Fistula Treatment Market - North America
    • 9.3.1.North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.3.2.North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.3.3.North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.3.4.North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.5.Anal Fistula Treatment Market - U.S.
      • 9.3.5.1.U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.6.Anal Fistula Treatment Market - Canada
      • 9.3.6.1.Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.4.Anal Fistula Treatment Market - Europe
    • 9.4.1.Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.5.Anal Fistula Treatment Market - UK
      • 9.4.5.1.UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.6.Anal Fistula Treatment Market - France
      • 9.4.6.1.France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.7.Anal Fistula Treatment Market - Germany
      • 9.4.7.1.Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.8.Anal Fistula Treatment Market - Italy
      • 9.4.8.1.Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.9.Anal Fistula Treatment Market - Spain
      • 9.4.9.1.Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.10.Anal Fistula Treatment Market - Netherlands
      • 9.4.10.1.Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.11.Anal Fistula Treatment Market - Russia
      • 9.4.11.1.Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.5.Anal Fistula Treatment Market - Asia Pacific
    • 9.5.1.Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.5.Anal Fistula Treatment Market - China
      • 9.5.5.1.China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.6.Anal Fistula Treatment Market - India
      • 9.5.6.1.India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.7.Anal Fistula Treatment Market - Japan
      • 9.5.7.1.Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.8.Anal Fistula Treatment Market - Malaysia
      • 9.5.8.1.Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.9.Anal Fistula Treatment Market - Indonesia
      • 9.5.9.1.Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.10.Anal Fistula Treatment Market - South Korea
      • 9.5.10.1.South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.6.Anal Fistula Treatment Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.5.Anal Fistula Treatment Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.6.Anal Fistula Treatment Market - South Africa
      • 9.6.6.1.South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.7.Anal Fistula Treatment Market - Israel
      • 9.6.7.1.Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.8.Anal Fistula Treatment Market - UAE
      • 9.6.8.1.UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.7.Anal Fistula Treatment Market - Latin America
    • 9.7.1.Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.5.Anal Fistula Treatment Market - Mexico
      • 9.7.5.1.Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.6.Anal Fistula Treatment Market - Brazil
      • 9.7.6.1.Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.7.Anal Fistula Treatment Market - Argentina
      • 9.7.7.1.Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Angiplast Pvt. Ltd.
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.Avante Health Solutions
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.Biolitec AG
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.Cliniva Healthcare
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.Cook Medical
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Gulmaher Surgico
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Integra LifeSciences
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.KARL STORZ
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Medtronic plc
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.Novo Surgical Inc.
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development
  • 11.11.Signum Surgical
    • 11.11.1.Company Overview
    • 11.11.2.Financial Performance
    • 11.11.3.Product Benchmarking
    • 11.11.4.Recent Development
  • 11.12.Sklar Surgical Instruments
    • 11.12.1.Company Overview
    • 11.12.2.Financial Performance
    • 11.12.3.Product Benchmarking
    • 11.12.4.Recent Development

List of Tables

  • Table 1 Global Anal Fistula Treatment Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Anal Fistula Treatment Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Anal Fistula Treatment Market, by End-use, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Anal Fistula Treatment Market, by Treatment Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 7 North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 8 North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 9 North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 12 U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 17 Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 20 Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 21 Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 28 France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 29 France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 31 UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 32 UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 33 UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 45 Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 Russia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 55 China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 56 China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 57 China: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 Japan: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 64 India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 65 India: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 76 South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 77 South Korea: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 81 Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 88 Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 89 Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 93 Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 100 UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 101 UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 108 South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 109 South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 112 Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 113 Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Anal Fistula Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Treatment Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Anal Fistula Treatment Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Treatment Type
  • Figure 9. Global Anal Fistula Treatment Market, by Treatment Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Anal Fistula Treatment Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-use
  • Figure 13. Global Anal Fistula Treatment Market, by End-use, 2021 & 2030 (USD Billion)